# q03 rev 1 - shortcut auditor (fresh shortcut-auditor, packet shortcut), 2026-10-06

Raw return as received:

I didn't read question.txt, and the packet showed no contamination.

answer: **5.2%.** For January 1 to June 30, 2025 (fiscal Q2 plus Q3 of FY2025), the restatement removed $156,324K of operating income and $2,998,256K of revenue from U.S. Healthcare Solutions, a margin of 5.21%.

verdict: clear

shortest_path:
1. The FY2025 Q4 release (D06, line 121) explains the change. Starting in fiscal 2026, U.S. Healthcare Solutions "will consist of U.S. Human Health (excluding legacy U.S. Consulting Services)". MWI Animal Health and U.S. Consulting Services move to "Other". The fiscal year ends September 30, so January–June 2025 is fiscal Q2 plus Q3.
2. Figures as originally reported (in thousands):
   - D02, three months ended March 31, 2025 (lines 402/410): revenue $68,283,831, operating income $1,033,150.
   - D04, three months ended June 30, 2025 (lines 423/431): revenue $72,876,563, operating income $901,793.
3. Restated prior-year figures from the FY2026 releases:
   - D03, three months ended March 31, 2025 (lines 447/456): revenue $66,819,265, operating income $944,969.
   - D05, three months ended June 30, 2025 (lines 456/465): revenue $71,342,873, operating income $833,650.
4. Removed amounts:
   - Revenue: 1,464,566 + 1,533,690 = 2,998,256
   - Operating income: 88,181 + 68,143 = 156,324
   - Margin: 156,324 / 2,998,256 = 5.214%, which rounds to **5.2%**
5. Checks:
   - The restatement only moves amounts between segments. Consolidated revenue and total segment operating income are the same before and after: Q2 $75,453,673 / $1,192,264; Q3 $80,663,532 / $1,058,331.
   - Each quarter balances. Amounts removed from U.S. Healthcare Solutions plus amounts removed from International, adjusted for intersegment eliminations, equal "Other" exactly (Q2 operating income: 88,181 + 4,703 − 33 = 92,851).
   - A second route gives the same numbers. Original: D04 nine-month total minus Q1 (D02 six-month total minus Q2) = 141,160,394 revenue and 1,934,943 operating income. Restated: D05 nine-month total minus D01 restated Q1 = 138,162,138 and 1,778,619. The differences are again 2,998,256 and 156,324.

sufficient_documents: Four documents are needed: D02 + D04 + D03 + D05.
- D06 can replace D04: fiscal-year total minus Q4 gives the same nine-month totals (215,193,522 / 2,702,287).
- D01 can replace D03, using the D05 nine-month total minus D01's restated Q1.
- D02 and D05 can't be replaced. D02 is the only source of original Q2 figures, and D05 is the only source of restated April–June 2025 figures.
- No single document contains both original and restated figures for the same period.

searches:
- Search terms: "U.S. Healthcare Solutions" table rows; recast/restat/reclassif/realign/reportable segment; "previously reported"/"as reported"/"revised"/conform; MWI/Animal Health/Consulting Services.
- Coverage: the manifest, all six text files (segment tables and segment narratives in D01, D03 and D05), and the D06 restatement paragraph. All eight key figures were confirmed in the matching docs/ source files.
- No narrative gives the removed amounts or margin. D01, D03, D05 and D06 give revised fiscal 2025 annual figures, but only rounded and only for the full year ($285.0B revenue, $3.3B adjusted operating income). They can't produce the answer for this period.

readings/gaps:
- Other readings, all rejected:
  - Fiscal first half (October–March): 168,600 / 2,942,400 = 5.7%. Wrong period.
  - Nine months October–June: 236,743 / 4,476,090 = 5.3%.
  - Using "Other" as a stand-in (restated January–June): 179,955 / 4,063,871 = 4.4%. Wrong, because Other also includes Profarma and PharmaLex pieces taken from International, plus elimination effects.
  - Change in the segment's own margin: 1.371% to 1.287%, a drop of 0.08 points. Not what "margin of the removed amounts" asks.
  - Averaging the two quarterly margins (6.02% and 4.44%) also gives 5.2%.
- Difficulty risk: once the four tables are found, the math is just subtraction and one division. The main reasoning step is mapping calendar January–June to fiscal Q2 and Q3.
- Gap: D06 and later releases cite Exhibit 99.2 to the November 5, 2025 8-K for revised segment detail. That exhibit isn't in the packet and wasn't consulted. No extraction gaps were found.

Key files (under D:\Dev\Docket\tasks\aq-01322\runs\q03-r1-v2-f22ab113bf6643e158188f01ab43b59b6aa5e4054abc7a10354193735d51d57a\shortcut\text\):
- D02.txt
- D03.txt
- D04.txt
- D05.txt
- D01.txt
- D06.txt
